| 68.8 -1.61 (-2.29%) | 10-16 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 87.13 | 1-year : | 93.17 |
| Resists | First : | 74.59 | Second : | 79.76 |
| Pivot price | 69.93 |
|||
| Supports | First : | 66.23 | Second : | 55.1 |
| MAs | MA(5) : | 70.27 |
MA(20) : | 70.54 |
| MA(100) : | 66.92  |
MA(250) : | 67.8 |
|
| MACD | MACD : | -0.9 |
Signal : | -0.9 |
| %K %D | K(14,3) : | 47.1 |
D(3) : | 52.7 |
| RSI | RSI(14): 43.2 |
|||
| 52-week | High : | 85.83 | Low : | 50.81 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ RDNT ] has closed above bottom band by 27.3%. Bollinger Bands are 49.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 3 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 70.82 - 71.18 | 71.18 - 71.47 |
| Low: | 67.67 - 68.05 | 68.05 - 68.36 |
| Close: | 68.25 - 68.84 | 68.84 - 69.32 |
RadNet, Inc. operates as a prominent healthcare services company specializing in outpatient diagnostic imaging across the United States. Their comprehensive offerings span a broad spectrum of advanced imaging techniques, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, and general diagnostic radiology, along with various specialized procedures. Beyond direct patient services, the company also plays a significant role in developing and marketing specialized computerized systems for the diagnostic imaging sector, such as picture archiving communication systems (PACS) and associated support. Furthermore, RadNet is at the forefront of integrating artificial intelligence (AI) solutions, designing and deploying AI suites to augment radiologist interpretation, particularly in mammography, and extending these AI capabilities to lung and prostate cancer diagnostics. As of December 31, 2021, its operational footprint included ownership and management of 347 centers situated across seven states: Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Established in 1981, the company maintains its headquarters in Los Angeles, California.
Sat, 17 Oct 2026
What RadNet (RDNT) Earnings Beat Means For Shareholders - Yahoo Finance
Fri, 16 Oct 2026
RadNet, Inc. (RDNT) Stock Forecasts - Yahoo! Finance Canada
Wed, 14 Oct 2026
RadNet, Inc. (RDNT) Stock Forecasts - Yahoo Finance
Wed, 14 Oct 2026
RadNet Inc (RDNT) Shares Fall 3.3% -- What GF Score of 79 Tells Investors - GuruFocus
Tue, 13 Oct 2026
Here’s How Much You Would Have Made Owning RadNet Stock In The Last 15 Years - Benzinga
Sat, 10 Oct 2026
RadNet, Inc. (RDNT) Stock Forecasts - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Diagnostics & Research
|
|
| Shares Out | 79 (M) |
| Shares Float | 66 (M) |
| Held by Insiders | 9.9 (%) |
| Held by Institutions | 105.5 (%) |
| Shares Short | 9,360 (K) |
| Shares Short P.Month | 9,940 (K) |
| EPS | -0.28 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 13.93 |
| Profit Margin | -1 % |
| Operating Margin | 7.8 % |
| Return on Assets (ttm) | 1.7 % |
| Return on Equity (ttm) | 1.5 % |
| Qtrly Rev. Growth | 25 % |
| Gross Profit (p.s.) | 4.98 |
| Sales Per Share | 28.84 |
| EBITDA (p.s.) | 3.5 |
| Qtrly Earnings Growth | -49.1 % |
| Operating Cash Flow | 310 (M) |
| Levered Free Cash Flow | 158 (M) |
| PE Ratio | -254.82 |
| PEG Ratio | 0.9 |
| Price to Book value | 4.93 |
| Price to Sales | 2.38 |
| Price to Cash Flow | 17.46 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|